Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 6
2004 4
2005 5
2006 3
2007 2
2008 2
2009 1
2010 6
2011 6
2012 10
2013 4
2014 7
2015 8
2016 1
2017 2
2018 5
2019 5
2020 1
2021 3
2022 4
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Janus Kinases in Leukemia.
Raivola J, Haikarainen T, Abraham BG, Silvennoinen O. Raivola J, et al. Among authors: silvennoinen o. Cancers (Basel). 2021 Feb 14;13(4):800. doi: 10.3390/cancers13040800. Cancers (Basel). 2021. PMID: 33672930 Free PMC article. Review.
Aiming for the pocket.
Silvennoinen O, Haikarainen T, Virtanen A. Silvennoinen O, et al. Nat Chem Biol. 2022 Dec;18(12):1296-1297. doi: 10.1038/s41589-022-01120-5. Nat Chem Biol. 2022. PMID: 36097296 No abstract available.
Editorial: JAK inhibition in autoimmune and inflammatory diseases.
Telliez JB, Gadina M, Ghoreschi K, Silvennoinen O, Spinelli FR. Telliez JB, et al. Among authors: silvennoinen o. Front Immunol. 2022 Dec 28;13:1120281. doi: 10.3389/fimmu.2022.1120281. eCollection 2022. Front Immunol. 2022. PMID: 36643918 Free PMC article. No abstract available.
Nucleotide-binding mechanisms in pseudokinases.
Hammarén HM, Virtanen AT, Silvennoinen O. Hammarén HM, et al. Among authors: silvennoinen o. Biosci Rep. 2015 Nov 20;36(1):e00282. doi: 10.1042/BSR20150226. Biosci Rep. 2015. PMID: 26589967 Free PMC article. Review.
Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain.
Virtanen AT, Haikarainen T, Sampathkumar P, Palmroth M, Liukkonen S, Liu J, Nekhotiaeva N, Hubbard SR, Silvennoinen O. Virtanen AT, et al. Among authors: silvennoinen o. Pharmaceuticals (Basel). 2023 Jan 4;16(1):75. doi: 10.3390/ph16010075. Pharmaceuticals (Basel). 2023. PMID: 36678572 Free PMC article.
New scaffolds for type II JAK2 inhibitors overcome the acquired G993A resistance mutation.
Arwood ML, Liu Y, Harkins SK, Weinstock DM, Yang L, Stevenson KE, Plana OD, Dong J, Cirka H, Jones KL, Virtanen AT, Gupta DG, Ceas A, Lawney B, Yoda A, Leahy C, Hao M, He Z, Choi HG, Wang Y, Silvennoinen O, Hubbard SR, Zhang T, Gray NS, Li LS. Arwood ML, et al. Among authors: silvennoinen o. Cell Chem Biol. 2023 Jun 15;30(6):618-631.e12. doi: 10.1016/j.chembiol.2023.05.007. Epub 2023 Jun 7. Cell Chem Biol. 2023. PMID: 37290440
Janus kinases to jakinibs: from basic insights to clinical practice.
Gadina M, Le MT, Schwartz DM, Silvennoinen O, Nakayamada S, Yamaoka K, O'Shea JJ. Gadina M, et al. Among authors: silvennoinen o. Rheumatology (Oxford). 2019 Feb 1;58(Suppl 1):i4-i16. doi: 10.1093/rheumatology/key432. Rheumatology (Oxford). 2019. PMID: 30806710 Free PMC article. Review.
90 results